Results 231 to 240 of about 126,420 (329)

Unlocking the Tyranny of Modern Thinking: Keys From Anthropology, Psychology, Neuroscience, and Buddhism

open access: yesAnthropology of Consciousness, EarlyView.
ABSTRACT One barrier to mental health and a common focus of psychotherapy is the tendency to identify with relentless, often self‐critical thinking that searches for faults, becomes easily distracted, and pulls individuals away from the present moment.
Barbara Carter
wiley   +1 more source

<sup>18</sup>F-FDG PET/CT Reveals Characteristic Prefrontal-Posterior Cingulate Hypometabolism in anti-AMPAR Encephalitis to Understand Cerebral Function: Insights From an Eight-Patient Cohort. [PDF]

open access: yesCNS Neurosci Ther
Cong H   +17 more
europepmc   +1 more source

Low episodic memory performance in cognitively normal elderly subjects is associated with increased posterior cingulate gray matter N-acetylaspartate: a 1H MRSI study at 7 Tesla

open access: bronze, 2016
Simon J. Schreiner   +16 more
openalex   +2 more sources

Psilocybin as a novel treatment for chronic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey   +3 more
wiley   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

open access: yesBritish Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy